Neurology Flashcards
What is an astrocytoma.
Intracranial tumours that are derived from astrocytes.
Describe the demographics of an astrocytoma.
They may occur at any age,although they are more common in males.
How can astrocytomas be classified?
- Low grade: Grade I and II, more common in children
- High grade: Grade III and IV, more common in adults
Describe the presentation of grade I astrocytomas.
Grade I astrocytomas are often found within the cerebellum and as such tend to present with symptoms relating to balance and coordination.
Typically benign in nature.
Describe the presentation of grade II astrocytomas.
Grade II tumours often present with seizures and have the potential to become malignant.
Describe the pathology behind MS.
The Oligodendrocytes degenerate for an unknown reason.
It is an acquired, chronic autoimmune disorder affecting the CNS. It results in demyelination, gliosis and neuronal damage.
Describe how a patient with MS would present.
Either sensory or motor symptoms as the conduction of signals along a neurone slows down.
Symptoms involve multiple branches of the nervous system, such as vision problems, weakness, pains, tingling and numbness.
Describe the pathology behind Alzheimer’s disease.
Mass degeneration occurs, commonly targeting the temporal and parietal lobes which cause a wide range of symptoms.
Describe the three disease patterns of MS.
- Relapsing-remitting: Patients face episodes of remission (during which no symptoms are present) and exacerbations of the disease.
- Primary progressive: After onset of disease there is steady progression and worsening of the disease.
- Secondary Progressive: Initially the MS is of relapsing-remitting pattern however at some point the disease course changes and the neurological function gradually worsens.
Give an example of a therapy that has proven useful in terms of managing acute exacerbations of MS.
High dose IV corticosteroids
Describe the pathology behind Guillain-Barré Syndrome.
A rapid onset of muscle weakness caused by autoimmune damage to the peripheral nervous system.
The cause is unknown, but the underlying mechanism is damage to the myelin sheath of peripheral nerves by the body’s immune system.
Describe how a patient with Guillain-Barré Syndrome would present.
Initial symptoms usually include changes to sensation or pain and muscle weakness. These begin distally in the feet and hands and then typically spreads proximally to the arms and upper body.
Describe why Guillain-Barré Syndrome can be life threatening in the acute phase.
If the respiratory muscles are affected – this requires mechanical ventilation.
Describe the treatment options for Guillain-Barré Syndrome.
- Supportive care
- Plasmapheresis
- Intravenous immunoglobulins.
Name three conditions that Acetylcholinesterase Inhibitors can be used in the treatment of.
- Myasthenia gravis
- Alzheimer’s disease
- Glaucoma